DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 088101
The generic ingredient in NAFAZAIR is naphazoline hydrochloride. There are seven drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the naphazoline hydrochloride profile page.
Summary for 088101
Tradename: | NAFAZAIR |
Applicant: | Pharmafair |
Ingredient: | naphazoline hydrochloride |
Patents: | 0 |
Therapeutic Class: | Ophthalmic Agents |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 088101
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | 0.1% | ||||
Approval Date: | Apr 15, 1983 | TE: | RLD: | No |
Complete Access Available with Subscription